期刊文献+

抗菌药物血脑屏障通透能力概述 被引量:13

Blood-brain Barrier Permeability of Antibacterial Drugs:Literature Review and Analysis
在线阅读 下载PDF
导出
摘要 本文通过对抗菌药物通过血脑屏障及其影响因素进行分析和总结,发现β-内酰胺及酶抑制剂、第三代头孢菌素和万古霉素等抗菌药物在脑膜炎时的血脑屏障通透率较为理想,抗菌效果显著,安全性较高,可广泛用于神经外科。 Through analyzing and summarizing the blood-brain barrier permeability rate of different antimicrobials and factors, we found that β-Lactam and β-Lactam enzyme inhibitors antibiotics, third-generation cephalosporins and vancomycin were widely used in neurosurgery because of the low toxicity and good penetration into cerebrospinal fluid in the presence of meningitis.
出处 《药品评价》 CAS 2012年第35期32-36,共5页 Drug Evaluation
关键词 抗菌药物 血脑屏障 脑脊液 通透率 Antimicrobials, Blood Brain Barrier (BBB) Cerebrospinal fluid (CSF) Permeability Rate
  • 相关文献

参考文献22

  • 1Nau R, S3rgel F, Prange HW, et al. Pharmacokinetic Optimisation of the Treatment of Bacterial Central Nervous System Infections[J]. Clin Pharmacokinet, 1998, 35 (3): 223-246.
  • 2Nau R, Kinzig-Schiooersk SM, S6rgel F, et al. Knetics of Piperacillin and Tazobactam in Ventricular Cerebrospinal Fluid of Hydrocephalic Patients[J]. Antimicrobial Agents and Chemotherapy, 1997;41 (5):987-91.
  • 3Miranda J, Tunkel AR. Strategies and New Developments in the Management of Bacterial Meningitis[J]. Infectious Disease Clinics of North America, 2009, 23(4): 925-943.
  • 4Shaban L, Siam R.Prevalence and antimicrobial resistance pattern of bacterial meningitis in Egypt[J].Ann Clin Microbiol Antimicrob,2009,8:26.
  • 5Del Rio Mde L, Chrane DF, Shelton S,et al. Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis[J]. Antimicrob Agents Chemother, 1982,22(6):990-994.
  • 6Buke AC, Cavusoglu C, Karasulu E, et al. Does dexamethasone affect ce~iazone penetration into cerebrospinal fluid in adult bacterial meningitis[J]. International Journal of Antimicrobial Agents, 2003, 21 (5): 452-456.
  • 7Palacios F J, Mochn MC, Snchez JC,et al. Validation of an HPLC Method for Determination of Cefepime (a Fourth-GenerationCephalosporin). Determination in Human Serum, Cerebrospinal Fluid, and Urine. Pharmacokinetic Profiles[J].Chromatograph ia,2005,62(7-8):355-361.
  • 8Cable D, Overturf G, Edralin G, et al. Concentrations of Cefoperazone in Cerebrospinal Fluid During Bacterial Meningitis[J]. Antimicrob Agents Chemother, 1983, 23(5): 688-691.
  • 9Schaad UB, McCracken GH Jr, Iqarelkeld N, etal. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants[J].J Pediatr,1981,98(1): 129-136.
  • 10Nau R, Lassek C, Kinzig-Schiooersk SM, et al. Disposition and Elimination of Meropenem in Cerebrospinal Fluid of Hydrocephalic Patients with External Ventriculostomy[J]. Antimicrob Agents Chemother, 1998, 42(8): 2012-2016.

二级参考文献4

共引文献4

同被引文献95

引证文献13

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部